PayPay Securities’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History
Bought
Maintained
Sold
Other funds holding LABU
PayPay Securities's LABU Position: Q3 2026 in Review
PayPay Securities increased its Direxion Daily S&P Biotech Bull 3X ETF (LABU) stake by 22% in Q3 2026, buying an estimated $2.5K and bringing the position to 50 shares worth $13.3K. The position accounts for 0.46% of the portfolio, ranked #44.
PayPay Securities first reported a position in LABU in Q1 2023 and has held it in 15 quarters since. The position peaked at $56.5K in Q2 2023. 38 funds tracked by Wall St. Rank hold LABU as of Q3 2026.
- PayPay Securities held 50 shares of Direxion Daily S&P Biotech Bull 3X ETF worth $13.3K as of Q3 2026.
- PayPay Securities bought 9 Direxion Daily S&P Biotech Bull 3X ETF shares in Q3 2026, an estimated $2.5K.
- Direxion Daily S&P Biotech Bull 3X ETF made up 0.46% of PayPay Securities's portfolio in Q3 2026, its #44 holding.
- PayPay Securities first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q1 2023 and has held it in 15 quarters since.
- PayPay Securities's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $56.5K in Q2 2023.
- 38 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q3 2026.
Based on PayPay Securities's 13F filing for Q3 2026, filed 27 Oct 2026.